Skip to main content

Table 2 Respiratory Symptoms and Health-Related Quality of Life Associated with Sarcopenic Obesity in Patients with COPD

From: Clinical impacts of sarcopenic obesity on chronic obstructive pulmonary disease: a cross-sectional study

Variable

NBC

(n = 66)

Obesity

(n = 59)

Sarcopenia

(n = 54)

Sarcopenic Obesity

(n = 19)

P-value

mMRC score

0.84 ± 0.99

1.59 ± 1.26*

1.90 ± 1.24*

3.09 ± 1.04*, #, &

< 0.001

CAT scores

10.69 ± 6.73

12.81 ± 7.18

16.26 ± 9.53*

23.30 ± 8.37*, #, &

< 0.001

SGRQ

     

SGRQ activity score

25.47 ± 18.90

26.65 ± 23.46

36.35 ± 23.28

53.33 ± 18.04*, #, &

0.006

SGRQ impact score

10.61 ± 11.88

18.29 ± 17.41

25.64 ± 13.38*

66.40 ± 14.40*, #, &

< 0.001

SGRQ symptoms score

19.44 ± 13.70

26.65 ± 23.46

39.29 ± 21.78*

63.00 ± 14.74*, #, &

< 0.001

Total score

17.00 ± 13.86

25.29 ± 20.33

32.53 ± 16.47*

58.17 ± 14.11*, #, &

< 0.001

  1. NBC, Normal Body Composition; mMRC, modified Medical Research Council dyspnea scale
  2. Values are given as percentage, mean (SD), or median (interquartile range) and χ2, 1-way ANOVA, or Kruskal–Wallis ANOVA on Ranks P values are indicated respectively, as appropriate
  3. *P < 0 0.05 compared with normal body composition
  4. #P < 0.05 compared with obesity
  5. &P < 0.05 compared with sarcopenia